Mariner
RGLS

Mariner’s Regulus Therapeutics RGLS Stock Holding History

Mariner’s Portfolio RGLS Stock Details RGLS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q4 		– Sell
-130
Closed -$3K – 884
2018
Q3 		$3K Hold
130
– – ﹤0.01% 806
2018
Q2 		$10K Hold
130
– – ﹤0.01% 785
2018
Q1 		$11K Sell
130
-182
-58% -$24.4K ﹤0.01% 639
2017
Q4 		$39K Hold
312
– – ﹤0.01% 569
2017
Q3 		$47K Hold
312
– – ﹤0.01% 499
2017
Q2 		$37K Hold
312
– – ﹤0.01% 496
2017
Q1 		$62K Buy
312
+142
+84% +$27K ﹤0.01% 579
2016
Q4 		$46K Buy
170
+45
+36% +$14.6K ﹤0.01% 552
2016
Q3 		$50K Buy
+125
New +$51.4K ﹤0.01% 648

Other funds holding RGLS

BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
WS
Wedbush Securities Los Angeles, California $3.43B AUM 24.13% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
PAM
Panagora Asset Management Boston, Massachusetts $26.7B AUM 36.4% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return